Reata rises on renal interest from Amgen

By Elizabeth S. Eaton, Staff Writer | Feb 1, 2020 | 2:37 AM GMT

Reata gained $24.75 (13%) to $218.79 Friday, adding about $750 million in market cap, after Amgen expressed